• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机模拟方法:丛生草提取物对H37Rv菌株的抗结核活性

In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain.

作者信息

Moreno-Ceballos Andrea, Caballero Norma A, Castro María Eugenia, Perez-Aguilar Jose Manuel, Mammino Liliana, Melendez Francisco J

机构信息

Laboratorio de Química Teórica, Centro de Investigación, Departamento de Fisicoquímica, Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Edif. FCQ10, 22 Sur y San Claudio, Ciudad Universitaria, Col. San Manuel, Puebla C.P. 72570, Mexico.

Facultad de Ciencias Biológicas, Benemérita Universidad Autónoma de Puebla, Edif. BIO1, 22 Sur y San Claudio, Ciudad Universitaria, Col. San Manuel, Puebla C.P. 72570, Mexico.

出版信息

Curr Issues Mol Biol. 2024 Jun 27;46(7):6489-6507. doi: 10.3390/cimb46070387.

DOI:10.3390/cimb46070387
PMID:39057029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11275643/
Abstract

Tuberculosis is a highly lethal bacterial disease worldwide caused by (). Caespitate is a phytochemical isolated from , a plant used in African traditional medicine that shows anti-tubercular activity, but its mode of action remains unknown. It is suggested that there are four potential targets in , specifically in the H37Rv strain: InhA, MabA, and UGM, enzymes involved in the formation of 's cell wall, and PanK, which plays a role in cell growth. Two caespitate conformational structures from DFT conformational analysis in the gas phase (GC) and in solution with DMSO (CS) were selected. Molecular docking calculations, MM/GBSA analysis, and ADME parameter evaluations were performed. The docking results suggest that CS is the preferred caespitate conformation when interacting with PanK and UGM. In both cases, the two intramolecular hydrogen bonds characteristic of caespitate's molecular structure were maintained to achieve the most stable complexes. The MM/GBSA study confirmed that PanK/caespitate and UGM/caespitate were the most stable complexes. Caespitate showed favorable pharmacokinetic characteristics, suggesting rapid absorption, permeability, and high bioavailability. Additionally, it is proposed that caespitate may exhibit antibacterial and antimonial activity. This research lays the foundation for the design of anti-tuberculosis drugs from natural sources, especially by identifying potential drug targets in .

摘要

结核病是一种由()引起的全球范围内极具致死性的细菌性疾病。凯斯皮泰是从一种用于非洲传统医学的植物中分离出的一种植物化学物质,它具有抗结核活性,但其作用方式尚不清楚。研究表明,在(此处原文缺失具体内容)中,特别是在H37Rv菌株中有四个潜在靶点:参与(此处原文缺失具体内容)细胞壁形成的InhA、MabA和UGM酶,以及在细胞生长中起作用的PanK。从气相(GC)和二甲基亚砜(DMSO)溶液(CS)中的密度泛函理论(DFT)构象分析中选择了两种凯斯皮泰构象结构。进行了分子对接计算、MM/GBSA分析和ADME参数评估。对接结果表明,与PanK和UGM相互作用时,CS是凯斯皮泰的首选构象。在这两种情况下,凯斯皮泰分子结构特有的两个分子内氢键得以维持,以形成最稳定的复合物。MM/GBSA研究证实,PanK/凯斯皮泰复合物和UGM/凯斯皮泰复合物是最稳定的。凯斯皮泰显示出良好的药代动力学特征,表明其吸收快、渗透性好且生物利用度高。此外,有人提出凯斯皮泰可能具有抗菌和抗锑活性。这项研究为从天然来源设计抗结核药物奠定了基础,特别是通过确定(此处原文缺失具体内容)中的潜在药物靶点。

相似文献

1
In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain.计算机模拟方法:丛生草提取物对H37Rv菌株的抗结核活性
Curr Issues Mol Biol. 2024 Jun 27;46(7):6489-6507. doi: 10.3390/cimb46070387.
2
Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.对来自结核分枝杆菌的InhA、MabA和PanK酶与来自节节菜和海南梭罗的鞣花酸衍生物的分子对接研究。
In Silico Pharmacol. 2015 Dec;3(1):10. doi: 10.1186/s40203-015-0014-1. Epub 2015 Dec 8.
3
and evaluations of actinomycin Xand actinomycin D as potent anti-tuberculosis agents.并评估更生霉素 X 和更生霉素 D 作为有效的抗结核药物。
PeerJ. 2023 Mar 8;11:e14502. doi: 10.7717/peerj.14502. eCollection 2023.
4
In-silico and in-vitro assessments of some fabaceae, rhamnaceae, apocynaceae, and anacardiaceae species against Mycobacterium tuberculosis H37Rv and triple-negative breast cancer cells.计算机模拟和体外评估一些豆科、鼠李科、夹竹桃科和漆树科物种对结核分枝杆菌 H37Rv 和三阴性乳腺癌细胞的作用。
BMC Complement Med Ther. 2023 Jul 1;23(1):219. doi: 10.1186/s12906-023-04041-5.
5
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of H37Rv: Rifampicin Derivatives Target VapC2 of H37Rv.基于计算机鉴定利福平靶向 H37Rv 核糖核酸酶 VapC2 的新型衍生物:利福平衍生物靶向 H37Rv 的 VapC2。
Molecules. 2023 Feb 8;28(4):1652. doi: 10.3390/molecules28041652.
6
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.针对分枝杆菌 InhA 酶的吲嗪衍生物的抗结核活性和分子对接研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889.
7
4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.4-芳基-1,4-二氢吡啶类化合物作为潜在的烯酰基辅酶 A 还原酶抑制剂:抗结核活性及分子对接研究。
Curr Top Med Chem. 2021;21(4):295-306. doi: 10.2174/1568026620666201102121606.
8
Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of with Favorable Predicted Pharmacokinetic Profiles.基于结构的设计和虚拟组合文库的计算机筛选苯甲酰胺抑制 2-反式烯酰基辅酶 A 还原酶与有利的预测药代动力学特征。
Int J Mol Sci. 2019 Sep 24;20(19):4730. doi: 10.3390/ijms20194730.
9
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
10
Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.设计、合成和咪唑及苯并咪唑连接的乙硫异烟胺衍生物的分子对接研究,作为 InhA 的抑制剂和抗结核药物。
Bioorg Med Chem Lett. 2022 Mar 15;60:128604. doi: 10.1016/j.bmcl.2022.128604. Epub 2022 Feb 2.

引用本文的文献

1
In Silico Screening of 1,3,4-Thiadiazole Derivatives as Inhibitors of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2).1,3,4-噻二唑衍生物作为血管内皮生长因子受体-2(VEGFR-2)抑制剂的计算机模拟筛选
Curr Issues Mol Biol. 2024 Oct 6;46(10):11220-11235. doi: 10.3390/cimb46100666.

本文引用的文献

1
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用:进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.
2
Review on antibacterial activity of Himalayan medicinal plants traditionally used to treat pneumonia and tuberculosis.喜马拉雅药用植物治疗肺炎和肺结核的抗菌活性评价综述。
J Pharm Pharmacol. 2019 Nov;71(11):1599-1625. doi: 10.1111/jphp.13156. Epub 2019 Aug 29.
3
Multidrug-resistant tuberculosis.耐多药结核病
Lancet. 2019 Jul 27;394(10195):298. doi: 10.1016/S0140-6736(19)30696-8.
4
Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in : Efficacy and Safety Investigations.补骨脂酸的抗分枝杆菌、酶抑制及分子相互作用研究:疗效与安全性调查
J Clin Med. 2018 Aug 20;7(8):226. doi: 10.3390/jcm7080226.
5
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK.一种针对结核分枝杆菌 PyrG 和 PanK 的多靶点药物发现方法。
Sci Rep. 2018 Feb 16;8(1):3187. doi: 10.1038/s41598-018-21614-4.
6
Intramolecular Hydrogen Bond Expectations in Medicinal Chemistry.药物化学中的分子内氢键预期
ACS Med Chem Lett. 2017 Jan 18;8(2):139-142. doi: 10.1021/acsmedchemlett.7b00002. eCollection 2017 Feb 9.
7
Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis.验证CoaBC作为结核分枝杆菌辅酶A途径中的杀菌靶点
ACS Infect Dis. 2016 Dec 9;2(12):958-968. doi: 10.1021/acsinfecdis.6b00150. Epub 2016 Oct 5.
8
A Second, Druggable Binding Site in UDP-Galactopyranose Mutase from Mycobacterium tuberculosis?来自结核分枝杆菌的UDP-吡喃半乳糖变位酶中第二个可成药结合位点?
Chembiochem. 2016 Dec 2;17(23):2264-2273. doi: 10.1002/cbic.201600469. Epub 2016 Nov 7.
9
Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.对来自结核分枝杆菌的InhA、MabA和PanK酶与来自节节菜和海南梭罗的鞣花酸衍生物的分子对接研究。
In Silico Pharmacol. 2015 Dec;3(1):10. doi: 10.1186/s40203-015-0014-1. Epub 2015 Dec 8.
10
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.耐多药结核病和广泛耐药结核病
Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863. doi: 10.1101/cshperspect.a017863.